Boehringer Ingelheim releases complete opnMe library with 176 molecules for research
Boehringer Ingelheim is opening up its entire opnMe “Molecule-to-Order” library to the international research community with opn2SCREEN . The library includes 176 carefully characterized molecules (99 active ingredients and 77 negative controls) and is now available for systematic screening and profiling studies.
Scientists worldwide are invited to apply with innovative project ideas. We are looking for projects that use the entire library to investigate new biological questions in the context of human diseases. Projects in the fields of cardiovascular-metabolic diseases, immunology, respiratory diseases, neuroscience, oncology, eye health and sustainability research are particularly in demand.
The selected projects will receive the entire library free of charge in 384-well plate format (40 microliters of a 10 mM stick solution per well). The researchers work independently and can publish their results freely.
The application deadline is June 17, 2026. The first deliveries of the library are planned from the third quarter of 2026.
The initiative is part of Boehringer Ingelheim’s opnMe program, which has been supporting scientists worldwide for years with high-quality, well-characterized molecules to promote independent scientific innovation.
Further information:
opnme.com/collaborate-now/opn2screen-2026
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.
Most read
Wal Timmy: Environment Minister Backhaus ignored rescue technology that has been in place since 1983 The stranded humpback whale "Timmy" suffered severely for days in Mecklenburg-Western Pomerania beca...- Wal Timmy: Germany’s problem with euthanasia EDITORIAL. Letting Timmy suffer is more due to the German lack of experience and the bureaucratic hu...
- Impending fuel shortage: “If the laboratory fails, medical care will come to a standstill in large parts” DGKL CEO Jan Wolter explains the dramatic consequences of a potential fuel shortage for laboratory m...
